2 Oct, 2019

Sano featured in The Guardian

Over the weekend, The Guardian published an article about the future of genetic sequencing and focused on Sano's ongoing work and our recent kit launch.

Andrew Anthony, author of the article, discussed the rise of precision medicine and the use of genome sequencing in particular for those with rare diseases. This comes as, earlier this year, the British health secretary Matt Hancock said that: "Every genome sequence moves us a step closer to unlocking life-saving treatments.”

The article looks at the increasing popularity of genetic sequencing, and our unique role as 'a matchmaker between people with particular conditions (or a genetic predisposition to them) and researchers in related fields.' Which is a role that we are proud to occupy and a need in the industry that we currently see as being underserved.

As growing concerns for data privacy rise with other direct to consumer genetic sequencing, Sano has always put emphasis on user consent and protection of their data. Sano believe users permission should never be taken for granted as we believe that everyone should have full-ownership over their genetic data.

This focus on privacy is just as apparent with the release of Sano's kits, which include Genotyping, Exome Plus, and Whole Genome. In fact, the kits were launched in part due to a lack of transparency around data ownership in the wider field of consumer genetics companies.

Sano's sequencing kits are also different because of an emphasis on rigorous science. New reports are released on the platform regularly, and these are both thoroughly researched and easy to understand. We are not offering medical advice or diagnosis but instead focus on the contribution we can all make to the future of research. Our tests can help you contribute to scientific breakthroughs and make personalised medicine a reality.

We are excited to be highlighted in The Guardian's article on the future of genome sequencing, and agree that 'the greater the number of genomes sequenced, the more that balance will shift. And when that happens, genetic medicine is going to become much more precise and, ultimately, far more personalised.'

You can read the full article here.

Check out our kits here.

And can find out why we are launching a DTC genetic test here.

Follow us @sanogenetics

Discover the world of genetics

Join our community to learn more about your health and contribute to the development of medical research.

Sign Up

Related blogposts